[Application of ATG, anti-CD3, anti-CD52 and anti-CD20 antibodies to transplantation].
Sołdacki
Dariusz
D
Klinika Immunologii, Transplantologii i Chorób Wewnetrznych Instytutu Transplantologii AM w Warszawie. tornado@amwaw.edu.pl
Mucha
Krzysztof
K
D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000494:pharmacology; D015703:Antigens, CD / Q000276:immunology* / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000276:immunology; D000961:Antilymphocyte Serum; D017252:CD3 Complex / Q000276:immunology* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D015703:Antigens, CD; D018951:Antigens, CD20; D000961:Antilymphocyte Serum; D017252:CD3 Complex; D007166:Immunosuppressive Agents; D000074323:Alemtuzumab